PHI with varicose ulcer
How does this condition affect your private health insurance?
Ulcus varicosum, commonly known as a venous ulcer or venous stasis ulcer, is a chronic wound that develops on the lower legs, typically above the ankle. It is caused by chronic venous insufficiency, where impaired venous blood flow leads to increased pressure in the leg veins. This sustained high pressure damages capillaries, causing fluid and blood cells to leak into the surrounding tissues, leading to inflammation, tissue breakdown, and eventual ulcer formation. These ulcers are often painful, irregular in shape, and can be surrounded by discolored (hyperpigmented), hardened skin (lipodermatosclerosis). They are notoriously difficult to heal and prone to recurrence, significantly impacting quality of life.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 30%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to many months, potentially over a year for severe cases.
Duration of Illness (Lifetime)
Often chronic with frequent recurrences, lasting many years or a lifetime.
Cost of Treatment (Initial)
Moderate to high (e.g., several hundred to thousands of dollars/euros) including wound care, compression therapy, and potential debridement or minor surgical interventions.
Cost of Treatment (Lifetime)
High to very high (e.g., tens of thousands of dollars/euros) due to chronic nature, recurrent episodes, specialized dressings, medical appointments, and potential for more complex interventions.
Mortality Rate
Low (<1%) directly from the ulcer itself, but complications like severe infection (sepsis) can rarely be life-threatening, especially in immunocompromised individuals.
Risk of Secondary Damages
High (60-80%) including chronic pain, infection (cellulitis, osteomyelitis), lymphedema, limited mobility, social isolation, depression, and significant reduction in quality of life.
Probability of Full Recovery
Moderate (40-60% achieve initial healing), but recurrence rate is high (up to 70% within 5 years), meaning complete, permanent recovery without recurrence is lower.
Underlying Disease Risk
Very high (>90%) as it is a direct complication of chronic venous insufficiency, often associated with a history of deep vein thrombosis (DVT), obesity, heart failure, and immobility.